- Coronavirus Vaccinations – data on the coronavirus pandemic
- Vaccinuri anti-COVID-19 sigure în Europa – Comisia Europeană
- The COVID-19 vaccines are here: What comes next? – McKinsey, 9.01
- How Science Beat the Virus – The Atlantic, 1-2.21
- Bulgaria și-a schimbat strategia de vaccinare. Este aceasta calea spre succes? – RFI, 23.02
- Bulgaria renunță la strategia de vaccinare în etape, după ce doar 10% dintre cei dornici de imunizare s-au prezentat la data programării – 23.02
- What if Countries That Excel at Vaccinations Still Don’t Achieve Herd Immunity? Israel emerges as a test case – FP, 17.02
- Israel: Scădere cu 94% a cazurilor simptomatice de Covid-19 în rândul celor 600.000 de persoane care au primit două doze de vaccin Pfizer – 15.02
Postcards From the End of the Pandemic – FP, 5.02
In China, workers go first. At a Moscow clinic, every time slot is available. And some New Zealanders think they could do without. A regular check-in on the state of the world’s COVID-19 vaccine rollout.
‘People Are Scared’: U.S. Officials in Africa Fight a Resurgent COVID-19 – FP, 3.02
As a new variant of the coronavirus spreads across southern Africa, U.S. aid officials are worried about health care—and a lack of guidance from Washington. By Amy Mackinnon, Robbie Gramer
Why the EU has fallen behind on vaccines – Quartz, 4.02
How Europe fell behind on vaccines – Politico, 27.01
The EU secured some of the lowest prices in the world. At what cost?
- Israelul a plătit mai mult și oferă Pfizer acces la datele cetățenilor în schimbul milioanelor de doze de vaccin necesare – 18.01
- Israel: Un studiu pe sute de mii de persoane arată că vaccinarea a redus cu 33%, într-o lună, numărul de bolnavi de Covid-19 – 18.01
The Global Vaccine Rollout Is Failing—and That Puts Everyone, Everywhere, In Danger
The selfish reasons the United States and Europe must help poor countries deal with COVID-19. By Jonathan Tepperman
Is COVID-19 vaccine supply fair worldwide? – Al Jazeera, 20.01
- Millions of coronavirus vaccines have been administered in wealthy countries while in one of the world’s poorest, only 25 doses have been given. The global vaccine-sharing fund, Covax, says it is preparing to deliver its first supplies in February, but is competing with nations striking their own, lucrative deals with manufacturers to secure the majority of doses.
- As coronavirus continues to spread, who will ensure a fair distribution of the available vaccines?
How fair is the vaccine roll-out worldwide? – DW, 20.01
- The news organisation VICE has discovered the wealthy are paying big bucks for specially organised “vaccine holidays”. At a time of travel bans they take a luxury trip to India or the Emirates. Long enough to get their two jabs and fit in some sightseeing. Critics say using their money to jump the queue ahead of the more vulnerable is unacceptable.
India starts vaccinating its 1.3 billion people against COVID – DW, 16.01
- India’s COVID-19 vaccination program is getting underway. The country aims to inoculate one-quarter of its 1.3 billion people against the coronavirus by July. Two vaccines – both made in India – have been approved for emergency use. Prime Minister Narendra Modi said healthcare and other frontline workers will be among the first to get the shot. India has recorded over 10 million cases of the virus, the second-highest number in the world, after the United States.
Covid vaccination: A ‘bittersweet’ moment for India’s health workers – 16.01
- Front-line workers – from doctors, nurses and hospital assistants to those working in sanitation – are among the first Indians to get vaccinated against Covid-19.
Coronavirus: the race between vaccines and new variants – FT, 18.01
- Anna Gross lays out the threat new variants of the disease pose to the UK’s vaccination programme. The hopes of the rest of the world could rest upon whether Britain succeeds in its target of 15m vaccinations by mid-February.
UK vaccine campaign: 2.4 million people vaccinated as new vaccine centres are set up – 11.01
Pandémie de Covid-19 en Europe : l’épidémie accélère, le variant britannique inquiète – 11.01
- Commission lets Germany off the hook for coronavirus vaccine solidarity breach – Politico, 8.01
- Thanks to deep pockets, Germany snaps up extra coronavirus jabs – Politico, 7.01
Europe : la vaccination à plusieurs vitesses – 8.01
- Cette semaine, nous parlons de la question la plus polémique de la rentrée 2021 : la vaccination à travers l’Europe contre le Covid-19. Bien que la Commission Européenne ait précommandé 2 milliards de doses auprès de six laboratoires, elle est parfois accusée d’avoir misé sur les mauvais chevaux.
Coronavirus pandemic: EU doubles BioNTech/Pfizer vaccine order to 600 million doses – 8.01
- The #EU has struck a deal to double its supply of the BioNTech/#Pfizer#coronavirus vaccine to 600 million doses, European Commission chief Ursula von der Leyen said on Friday. Authorities in the 27-nation bloc have been hit with rising criticism that the vaccine rollout that started December 27 has been too slow.
The secrets to Israel’s coronavirus vaccination success – Politico, 11.01
Trei lucruri care fac Israelul să fie cu mulți pași înaintea statelor europene în cursa vaccinării – Nadav Eyal, spotmedia, 7.01
Covid-19 en Israël : le Parlement vote la prolongation du confinement – 8.01
- Le Parlement en Israël a voté jeudi la prolongation du confinement jusqu’au 21 janvier ainsi que de nouvelles restrictions après une augmentation des cas d’infections au nouveau coronavirus.
Vaccinating the world: How to make more from less – DW, 7.01
- The first option is to delay the second dose. That would mean more people could have a first shot, which might provide some protection. The UK and Denmark have approved the measure and are about to put it into practice. But some experts warn that immunity might wane in the weeks following the initial shot. That could create ideal circumstances for the virus to mutate and become resistant.
- The second idea is to cut the doses in half, which would double the number of people that could be vaccinated. While there are indications that the immune response is the same, experts say, we can’t know for sure.
- The third option is to combine two vaccines, so that the composition of the booster is different from the initial one. The reasoning behind that idea is that both the AstraZeneca and BioNTech vaccines target the viruses spike protein. But with two different methods.
- The problem is: None of the proposed alternatives has been tested so far.
- Retreat of the UK coronavirus lockdown skeptics – 6.01
- Italy’s 5Star Movement learns to love coronavirus vaccines – 4.01
As cases spike, Europe mulls delaying 2nd coronavirus vaccine shot – Politico, 5.01
UK enters 3rd lockdown + Israel 1st in vaccination numbers – DW, 5.01
The EU’s coronavirus vaccine blame game. Why so slow? – Politico, 4.01
EU vaccination discrepancy: Germany hands out 188,500 doses, France only 516 in same timeframe – BBC, 4.01
- Though scientists had warned the world was due a pandemic, no-one could have predicted the scale and impact of Covid-19. So should we expect more pandemics in the future?
South African coronavirus variant: What we know so far – Politico, 4.01
Covid vaccine shortages: Could delaying a 2nd dose be the answer? – DW, 1.01.21
- Many countries – including the US and Germany – are falling far behind projected rollout speeds. The main issue is that the BioNtech-Pfizer vaccine – the first one to be widely approved – requires cumbersome refrigeration at extreme temperatures and two shots within three weeks to be most effective. This has sparked a debate among experts about whether the time between doses should be stretched to 3 months. Some argue that it is better to give many people some resistance to the virus, than to give fewer people full protection.
- Britain recently became the first country to authorize the vaccine developed by AstraZeneca and Oxford University. Trial data suggests it is somewhat less effective, but much easier to store and transport. Experts say it could change the situation entirely. Unlike its Biontech-Pfizer competitor, this vaccine is more effective when the second dose is given three months later… leaving enough time to inoculate much of the population and endow them with partial immunity. The UK plans to vaccinate a million people per week from January 4th.
- But what may turn out to be the most promising development on the horizon is still pending approval. Johnson&Johnson’s Jannsen vaccine requires only one dose. That could simplify logistics considerably. If approved, this single-shot jab could be in use in by February. To ebb the alarming rise in COVID-19 deaths, governments are still scrambling to find a way to speed up vaccination schemes.
What are the differences between the three main COVID-19 vaccines? – 31.12.20
- Here we compare the coronavirus vaccines from Pfizer/BioNtech, Moderna and Oxford/AstraZeneca.
Inside A Drive-Through COVID-19 Vaccine Clinic – TIME, 30.12.20
Will Virus Mutations Threaten COVID-19 Vaccines? – FP, 29.12
We don’t yet know whether new variants of the coronavirus may impede vaccines’ efficacy. But they shouldn’t change anything about our approach to public health. By Deepti Gurdasani
It’s Time to Use Eminent Domain on the Coronavirus Vaccines – FP, 29.12
Respecting drug companies’ intellectual property rights during a pandemic doesn’t make medical, or economic, sense. By Arnab Acharya, Sanjay G. Reddy
Why it could be years before Africans have access to coronavirus vaccines – 28.12
- African nations do not currently know how many doses of vaccine they’ll receive. In Democratic Republic of Congo, vaccine storage challenges and cultural resistance to treatment will limit how quickly the population is vaccinated. But the biggest hurdle may be competition with other rich nations for a limited global supply.
Covid-19 : le vaccin ne va pas nous sauver tout de suite, voici pourquoi – Le Monde, 27.12
- Pfizer, Moderna, AstraZeneca… les vaccins de ces laboratoires vont-ils assurer une immunité globale suffisante pour arrêter la transmission du coronavirus ? Chacun d’entre eux affiche en tout cas des taux d’efficacité prometteurs oscillant entre 70 % et 95 %. Et en l’absence de traitement contre la maladie, la vaccination qui débute dimanche 27 décembre en France constitue un espoir important.
- Il reste néanmoins de nombreux paramètres à prendre en compte pour évaluer l’impact qu’ils auront dans les mois qui viennent. Leur efficacité dans la vie réelle sera-t-elle à la hauteur de celle mesurée lors des essais cliniques ? Assureront-ils une immunité suffisamment longue ? Combien faudra-t-il vacciner de personnes pour freiner l’épidémie ?
- Ces incertitudes nécessitent de réfléchir à des campagnes de vaccinations pertinentes pour mieux déterminer qui il faut vacciner en priorité et à quel rythme. L’espoir étant de revenir un jour à une « vie normale ».
Vaccines 27 MS – 27.12
‘Let’s get vaccinated’: Europe rolls out Covid-19 vaccine – 27.12
Coronavirus vaccinations roll out across Europe – DW, 27.12
- COVID-19 vaccinations have begun in countries across the European Union. The vaccine is seen as the first significant step forward in a crisis that has elevated health workers and scientists to heroes. Now it’s the turn of a new type of hero to roll up their sleeves, with Europe’s most elderly lining up for the vaccine.
- Supply of the vaccine is limited but demand is huge. With most EU countries receiving an initial batch of no more than 10-Thousand doses, each member state is prioritizing who gets the jab. Further supplies are expected in the New Year, but officials warn there’s a long way to go before everyone can be vaccinated.
COVID-19 vaccine delivery and vaccination across EU – 26.12
- Today is delivery day, and tomorrow vaccination against COVID-19 begins across the European Union. We protect our citizens together. The first vaccine against COVID-19 is available at the same time for all EU countries. More vaccines will follow soon, once they are proven to be safe and effective.
Germany to start immunizations. Brazil yet to approve a vaccine – 26.12
‘No exit’ from pandemic if vaccines are rejected: EU Commissioner Mariya Gabriel – 24.12
- As the first citizens from the #EU‘s 27 member states get ready to receive their much-awaited #Covid-19 vaccines, EU Commissioner Mariya Gabriel has defended the longer time it’s taken for the EU to authorise the #Pfizer-BioNTech jab.
The Vaccine Has a Serious Side Effect—A Positive One – FP, 22.12
It could make 2021 the year Americans rediscover science. By Jonathan Tepperman
Peste un milion de americani au fost vaccinați / Consilier în cadrul programului de vaccinare: Obiectivul imunizării a 20 de milioane de persoane până la sfârșitul anului probabil nu va fi atins – 24.12
Biden gets his first dose of coronavirus vaccine – 21.12
- President-elect Joe Biden received his first dose of Pfizer’s COVID-19 vaccine in front of television cameras in an effort to boost public confidence in the safety of the vaccine. Mr. Biden urged Americans to get the shot when they can, saying they have “nothing to worry about.”
Vaccines’ Story – 26.12
UE va achiziţiona 80 de milioane de doze suplimentare din vaccinul Moderna / Primul vaccin care va fi livrat statelor UE este cel produs de compania americană Pfizer în colaborare cu cea germană BioNTech -18.12
Ursula von der Leyen: Statele UE vor putea începe în aceeași zi vaccinarea anti-COVID / Margaritis Schinas, vicepreședintele CE: Vaccinul va fi un cadou de Crăciun pentru toţi cetăţenii continentului nostru – 16.12
First EU Covid-19 vaccinations likely before end of year, bloc’s commission chief says – 15.12
Germania speră să vaccineze 60% din populaţie până la sfârşitul verii – 15.12
Trusting a Covid-19 Vaccine: Where Do We Stand? – CSIS, 16.12
Critics don’t think government’s vaccine awareness campaign is doing enough to allay concerns – 15.12
Will a Covid vaccine be mandatory? – BBC, 4.12
“Mandatory COVID-19 vaccination: the arguments for and against”: Julian Savulescu & Sam Vanderslott – 3.12
How are European countries planning to vaccinate their citizens? – 4.12
Aproximativ 100 de milioane de americani ar putea fi vaccinați până la sfârșitul lunii februarie. Administrația Trump intenționează să folosescă două vaccinuri pentru a imuniza 40% din populația adultă a SUA – 3.12
‘Does the vaccine give lifelong immunity?’: Your questions answered – BBC, 3.12
Doctor says COVID-19 herd immunity still long way off as U.S. prepares for vaccine distribution – 1.12
Vaccin contre le Covid-19 : les cinq phases de vaccination recommandées par la HAS – 30.11
#Vaccines4All: General Assembly President pledges to boost global response to COVID-19 – 30.11
Disarming Vaccine Disinformation – CFR, 2.12
Fears vaccine misinformation could affect take-up – BBC, 1.12
Coronavirus vaccine hesitancy could spoil the party in 2021 – Politico, 25.11
Covid-19 : pourquoi livrer les vaccins est un immense défi logistique – 27.11
Now we must focus on how to distribute these COVID vaccines, says expert – 23.11
Covid-19 pandemic in Germany: Berlin launches national vaccination strategy – 27.11
Coronavirus pandemic in Spain: Comprehensive vaccination program to begin in January – 24.11
- Europa se vaccinează. Ce strategii de vaccinare au statele – 19.11
Vaccin contre le Covid-19 : beaucoup de Français traditionnellement septiques – 30.11
Covid-19: why vaccine mistrust is growing – The Economist, 18.11
- Responsabil OMS: Încrederea în vaccinuri este crucială pentru a stopa COVID-19 – 14.11
- Sondaj: Din trei germani, doi sunt pentru vaccinarea anti-Covid – 14.11
- Unul din 60 de italieni s-a infectat cu SARS-CoV-2. Un virusolug anunţă când va fi al treilea val – 14.11
- Premierul francez Jean Castex: Temerea mea este că francezii nu se vor vaccina atât de mult – 13.11
- Din trei germani, doi sunt pentru vaccinarea anti-Covid – DW, 13.11
- Fewer people say they would take a COVID-19 vaccine now than 3 months ago – WEF, 5.11